ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

Go back to ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.66 -0.2 (1.84%)
Previous Close $10.86    52 Week High $2.18 
Open $10.67    52 Week Low $0.30 
Day High $10.74    P/E N/A 
Day Low $10.62    EPS $-3.32 
Volume 125,480       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.66 -0.2 (1.84%)
Previous Close $10.86    52 Week High $2.18 
Open $10.67    52 Week Low $0.30 
Day High $10.74    P/E N/A 
Day Low $10.62    EPS $-3.32 
Volume 125,480